DE3017015C2 - - Google Patents
Info
- Publication number
- DE3017015C2 DE3017015C2 DE3017015A DE3017015A DE3017015C2 DE 3017015 C2 DE3017015 C2 DE 3017015C2 DE 3017015 A DE3017015 A DE 3017015A DE 3017015 A DE3017015 A DE 3017015A DE 3017015 C2 DE3017015 C2 DE 3017015C2
- Authority
- DE
- Germany
- Prior art keywords
- mmol
- added
- ether
- compound
- diazo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3535779A | 1979-05-02 | 1979-05-02 | |
US6974179A | 1979-08-27 | 1979-08-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3017015A1 DE3017015A1 (de) | 1980-11-20 |
DE3017015C2 true DE3017015C2 (sk) | 1989-04-20 |
Family
ID=26712031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19803017015 Granted DE3017015A1 (de) | 1979-05-02 | 1980-05-02 | Steroide, verfahren zu ihrer herstellung und sie enthaltende zubereitungen |
Country Status (16)
Country | Link |
---|---|
AT (1) | AT390794B (sk) |
AU (1) | AU532558B2 (sk) |
CA (1) | CA1154008A (sk) |
CH (1) | CH643863A5 (sk) |
DE (1) | DE3017015A1 (sk) |
DK (1) | DK166501B1 (sk) |
ES (1) | ES8105012A1 (sk) |
FR (1) | FR2455610A1 (sk) |
GB (1) | GB2048888B (sk) |
IE (1) | IE49704B1 (sk) |
IL (1) | IL59934A (sk) |
IT (1) | IT1188932B (sk) |
NL (1) | NL191387C (sk) |
NO (1) | NO154884C (sk) |
NZ (1) | NZ193527A (sk) |
SE (1) | SE448097B (sk) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8503940D0 (en) * | 1985-02-15 | 1985-03-20 | Erba Farmitalia | 4-substituted androstendione derivatives |
NZ239141A (en) * | 1990-08-01 | 1994-04-27 | Merrell Dow Pharma | 4-amino-delta-4,6-steroids; preparatory processes and pharmaceutical compositions |
AU637247B2 (en) * | 1990-08-01 | 1993-05-20 | Merrell Dow Pharmaceuticals Inc. | 4-amino-delta4-steroids and their use as 5alpha-reductase inhibitors |
US5143909A (en) * | 1991-03-19 | 1992-09-01 | Merrell Dow Pharmaceuticals Inc. | Aminosteroids in a method for inhibiting c17-20 lyase |
EP0794456B1 (en) | 1996-03-07 | 2003-01-29 | Agfa-Gevaert | Method of reproducing an electronically stored medical image on a light-sensitive photographic material |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3917829A (en) * | 1971-11-08 | 1975-11-04 | Research Corp | Novel methods of inhibiting the activity of testosterone 5{60 -reductase |
US4088760A (en) * | 1976-06-23 | 1978-05-09 | Richardson-Merrell Inc. | Testosterone 5α-reductase inhibitors |
-
1980
- 1980-04-21 CA CA000350283A patent/CA1154008A/en not_active Expired
- 1980-04-22 IE IE806/80A patent/IE49704B1/en not_active IP Right Cessation
- 1980-04-23 AU AU57747/80A patent/AU532558B2/en not_active Expired
- 1980-04-24 NZ NZ193527A patent/NZ193527A/xx unknown
- 1980-04-25 GB GB8013775A patent/GB2048888B/en not_active Expired
- 1980-04-28 IL IL59934A patent/IL59934A/xx unknown
- 1980-04-29 ES ES491010A patent/ES8105012A1/es not_active Expired
- 1980-04-29 SE SE8003242A patent/SE448097B/sv not_active IP Right Cessation
- 1980-04-30 NO NO801254A patent/NO154884C/no unknown
- 1980-04-30 CH CH335980A patent/CH643863A5/de not_active IP Right Cessation
- 1980-04-30 IT IT48559/80A patent/IT1188932B/it active
- 1980-04-30 FR FR8009848A patent/FR2455610A1/fr active Granted
- 1980-04-30 AT AT0232880A patent/AT390794B/de not_active IP Right Cessation
- 1980-05-01 DK DK194180A patent/DK166501B1/da not_active IP Right Cessation
- 1980-05-01 NL NL8002529A patent/NL191387C/xx not_active IP Right Cessation
- 1980-05-02 DE DE19803017015 patent/DE3017015A1/de active Granted
Also Published As
Publication number | Publication date |
---|---|
ES491010A0 (es) | 1981-05-16 |
IT8048559A0 (it) | 1980-04-30 |
GB2048888B (en) | 1983-05-25 |
ATA232880A (de) | 1989-12-15 |
NZ193527A (en) | 1984-10-19 |
FR2455610A1 (fr) | 1980-11-28 |
ES8105012A1 (es) | 1981-05-16 |
AU5774780A (en) | 1980-11-06 |
IT8048559A1 (it) | 1981-10-30 |
IT1188932B (it) | 1988-01-28 |
CA1154008A (en) | 1983-09-20 |
IE800806L (en) | 1980-11-02 |
IL59934A0 (en) | 1980-06-30 |
AU532558B2 (en) | 1983-10-06 |
CH643863A5 (de) | 1984-06-29 |
SE8003242L (sv) | 1980-11-03 |
IL59934A (en) | 1983-06-15 |
NO154884B (no) | 1986-09-29 |
NL8002529A (nl) | 1980-11-04 |
SE448097B (sv) | 1987-01-19 |
NL191387C (nl) | 1995-07-03 |
NO801254L (no) | 1980-11-03 |
DE3017015A1 (de) | 1980-11-20 |
FR2455610B1 (sk) | 1982-04-30 |
NO154884C (no) | 1987-01-07 |
IE49704B1 (en) | 1985-11-27 |
GB2048888A (en) | 1980-12-17 |
AT390794B (de) | 1990-06-25 |
DK194180A (da) | 1980-11-03 |
NL191387B (nl) | 1995-02-01 |
DK166501B1 (da) | 1993-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4317817A (en) | Novel steroid 5α-reductase inhibitors | |
DE68921174T2 (de) | Phosphinsäure-Derivate von aromatischen Steroiden als 5-alpha Reduktase-Inhibitoren. | |
DE3124780C2 (sk) | ||
DE69027262T2 (de) | 4-Substitutiertes 17-beta-(Cyclopropyloxy)androst-5-en-3-beta-ol und seine Derivate, verwendbar als Inhibitoren der C17-20-Lyase | |
EP0701565A1 (de) | Neue prednisolonderivate | |
DE3124719C2 (de) | 10-(1,2-Propadienyl)-östr-4-en-3,17-dion, entsprechendes Zwischenprodukt und pharmazeutische Zubereitungen, die diese Verbindungen enthalten | |
DE3017015C2 (sk) | ||
DD145919B1 (de) | Verfahren zur herstellung von 14,1 -methylenderivaten der oestranreihe | |
DE3336292C2 (sk) | ||
DE69330465T2 (de) | Verfahren zur behandlung von chronischer prostatitis mit 17-beta-n-tertbutylcarbamoyl-4-aza-5 alpha-androst-1-en-3-one | |
CH621560A5 (en) | Process for the preparation of 3-ketosteroids disubstituted in position 16 | |
DE2954699C2 (sk) | ||
DE3402330A1 (de) | 1(alpha),2(alpha)-methylen-6-methylen- und 6(alpha)-methyl-pregnene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate | |
CH634083A5 (de) | Verfahren zur herstellung neuer kortikoide. | |
DE2711516C2 (de) | 17-Spirosultin-Derivate, Zwischenprodukte und Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
DE4326240A1 (de) | 15,15-Dialkyl-substituierte Derivate des Estradiols | |
DE2933258A1 (de) | Neue acetylenische derivate des androst-4-ens, deren herstellungsverfahren, deren verwendung als arzneimittel und die diese enthaltenden pharmazeutischen zusammensetzungen | |
DE69023721T2 (de) | In 3-Position Nitro-substituierte Steroid-Derivate. | |
DE3040200C2 (sk) | ||
DE2348197C3 (de) | Norethisteron-O-alkyloxime, Verfahren zu ihrer Herstellung sowie ihre Verwendung | |
DE4447401A1 (de) | 14,17-C¶2¶-überbrückte Steroide | |
DE68912422T2 (de) | 19-Fluor- oder Cyano-21-hydroxy-progesteron-Derivate als 19-Hydroxylase-Inhibitoren. | |
DE60026608T2 (de) | 3-methylen steroid derivate zur behandlung von autoimmunerkrankungen | |
DE2100319C3 (de) | Neue Östranverbindungen, ihre Herstellung und sie enthaltende Arzneimittel | |
DE2651364A1 (de) | Neue d-homosteroide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8110 | Request for examination paragraph 44 | ||
D2 | Grant after examination | ||
8364 | No opposition during term of opposition |